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mplex virus type 1, Acta PharmaceuticAbstract Herpes simplex virus type 1 (HSV-1), a neurotropic herpes virus, is able to establish a life-
long latent infection in the human host. Following primary replication in mucosal epithelial cells, the vi-
rus can enter sensory neurons innervating peripheral tissues via nerve termini. The viral genome is then
transported to the nucleus where it can be maintained without producing infectious progeny, and thus la-
tency is established in the cell. YineYang balance is an essential concept in traditional Chinese medicine
(TCM) theory. Yin represents stable and inhibitory factors, and Yang represents the active and aggressive
factors. When the organism is exposed to stress, especially psychological stress caused by emotional
stimulation, the YineYang balance is disturbed and the virus can re-engage in productive replication, re-
sulting in recurrent diseases. Therefore, a better understanding of the stress-induced susceptibility to
HSV-1 primary infection and reactivation is needed and will provide helpful insights into the effective
control and treatment of HSV-1. Here we reviewed the recent advances in the studies of HSV-1 suscep-
tibility, latency and reactivation. We included mechanisms involved in primary infection and the regula-
tion of latency and described how stress-induced changes increase the susceptibility to primary and
recurrent infections.
ª 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical
Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Herpes simplex virus type 1 (HSV-1), a ubiquitous human path-
ogen, is a neurotropic virus with a linear double-stranded DNA
genome that contains more than 80 open reading frames (ORFs)
and is about 152 kilo base-pairs (kbp) long. Upon primary
infection, the virus replicates within epithelial cells and undergoes
its typical lytic life cycle with a cascade of immediate early (IE),
early (E), and late (L) genes. Then, it enters axon terminals of
sensory neurons and is retrogradely transported to the corre-
sponding sensory ganglia, usually trigeminal ganglia (TG), where
a latent infection can be established. In response to a variety of
stressors, the latent virus can be reactivated periodically to resume
productive replication followed by the formation of infectious
virus, which is anterogradely transported back to peripheral tis-
sues or infects further neuronal cells to remain in host1,2. During
anterograde transport, both enveloped capsids and non-enveloped
capsids are detected3. Primary infection, latency and reactivation
complete the life cycle of the overall HSV-1 infection (Fig. 1). It is
also noteworthy that HSV-1 gene expression during latency and
reactivation might differ between rodent and mammal models4.
HSV-1 is commonly acquired during early childhood, pri-
marily through oral secretions; while sexual transmission is an
increasingly common cause of infection in some countries5.
Worldwide, the global prevalence of HSV-1 is approximately
90%, and in some rural areas, the seroprevalence is even higher,
up to 100%6e11. The success of HSV-1 infection can be attributed
to its ability to establish lifelong persistent infection of the host,
termed latency. In latent state, HSV-1 maintains the episomal viral
genome in neuronal nuclei without producing infectious progeny
for long period of time. Eventually, the virus can re-enter the lytic
replication program for productive replication, a process known as
reactivation. Reactivation ensures long-term persistence and
dissemination of the virus to further host cells or new hosts.
Furthermore, the lifespan of the latent infected cell is extended,
and thus the virus is able to escape immune surveillance.
HSV-1 has raised concerns because it can cause many diseases
of various severity. Acute HSV-1 infection can cause herpes
labialis (cold sores)12, gingivostomatitis13 and eczemaDisturbed YineYang balance: stress
a Sinica B, https://doi.org/10.1016/j.herpeticum14. It should be noted that, currently, there is no
treatment to completely remove HSV-1 once an individual is
infected. Reactivation of latently infected HSV-1 can cause
recrudescent lesions and is the main reason for herpes viral
encephalitis15e17 and herpetic keratitis18. Recurrent ocular infec-
tion can lead to irreversible corneal scarring and blindness19.
Increasing number of studies20,21 have confirmed HSV-1 as
pathogen directly related to nervous system degenerative diseases
like Alzheimer’s disease (AD). Reactivation of HSV-1 will in-
crease the risk of developing AD22. Importantly, an amplified
concentration of HSV-1 antibody and the use of antivirals can
antagonize the nerve damage of AD, which has also proven that
HSV-1 in latent status leads to long term damage to central ner-
vous system23,24. It might likewise be the cause of Meniere’s
disease, an inner ear disease with spinning sensation, loss of
hearing, and pressured feelings in the ear25. Hence, all these
findings have emphasized the importance on the study of HSV-1
latent infection.
As a rapidly developing systematical medical science, tradi-
tional Chinese medicine (TCM) is a systematical medicinal science
with an application history of over 2000 years in China, widely
spread in Asia. At present, a broad range of research in the field of
TCM is proceeding. As a treasured resource accumulated by the
continuous practice of Chinese people, it has inspired many new
discoveries in drug and therapeutic developments26e29. One of the
basic theories in the TCM field is the theory of YineYang balance,
which is also applied as a philosophical term. Therein, Yin repre-
sents the repressive and inhibitory factors, while Yang stands for the
active and aggressive factors. The confrontation, homeostasis, and
transformation between Yin and Yang compose the YineYang
balance. In different contexts and situations, the components of
Yin and Yang refer to different elements. For instance, in “Shang-
Huo” syndrome, the hyperactivity of Yang, in this case is “Huo”
(fire), causes increased neuroendocrine activation, hence breaking
the YineYang balance30,31. In TCM theory, the disturbance of
YineYang balance is an essential cause of diseases.
Stress has been defined as a non-specific reaction of an or-
ganism, which fails to respond appropriately to abnormal envi-
ronmental stimuli or emotional/physical threats. Disturbing theincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Figure 1 The life cycle of HSV-1 in neurons. During the establishment of latency, the virus invades the axonal termini through virion fusion
and travels to the nucleus through retrograde transport. Then the virus enters its latency. During latency, the virus maintains itself in the neuron as
an episome while silencing most of its genome and transcribing only a series of mRNAs, especially LAT. When stimulated by stress factors, the
virus reactivates and starts to massively replicate its lytic gene. The proliferated virus then travels to the axon termini through anterograde
transport. The complete assembly of the virion is finished in the process of egression. After the egression, the virus re-infects epithelial cells and
causes recurrent lesion.
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+ MODELYineYang balance, stress can increase the susceptibility to in-
fectious agents, influence the severity of infectious disease and
reactivate latent herpesviruses by significantly modulating the
central nervous (CNS), endocrine and immune systems. TCM
theory suggests that internal injury caused by excess of seven
emotions, named “Qi-Qing Nei-Shang”, also known as emotional
stress in modern medical science, disturbs YineYang balance,
“Qi-Xue” and viscera balance, inducing the stagnation of Qi32.
Chronically, the stagnation transforms into “Shang-Huo” syn-
drome, where Yang dominates Yin31. One of the typical symptoms
of “Shang-Huo” is heat sore on the face, which is related to the
reactivation of latent HSV-1 infection by modern medicine. Here
we review the latest insights into the mechanism of stress-induced
susceptibility to HSV-1 and its reactivation from latency in order
to shed light to future researches on HSV-1 latency and the
possible solutions to the effective control of latent HSV-1 infec-
tion reactivation.
2. Stress increases the susceptibility of HSV-1 infection by
disturbing host inner YineYang balance
It has been widely accepted that stress during HSV-1 infections
can influence the susceptibility, infection severity and infection
types33e36. The host defense against HSV-1 consists of three main
parts: innate immunity, adaptive immunity and intrinsicPlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.immunity37. Therein, innate and adaptive immunity are the main
defense strategies for most mitotic cells and have been investi-
gated more thoroughly38. Under normal condition, the host innate
and adaptive immunities perform in a cooperative and mutually
restrictive YineYang balance, ensuring adequate level of defense
against pathogens. However, when the balance is disturbed by
stimulations, the immunity balance begins to wander, which
consequently leads to immune compromise.
Our previous studies39e41 have already demonstrated that re-
straint stress is able to induce immune compromise, thereby
increasing the susceptibility to viral infection and the severity of
the infection, such as influenza; and that anti-stress treatments can
reverse such changes. Under normal conditions, the morbidity of
mice inoculated with H1N1 virus was about 30%, while the mice
pretreated with restraint stress for 22 h showed a morbidity of
100%42. Survival curves, lung index, virus nucleoprotein level and
immunohistochemistry results showed significantly increased
disease severity42e46. Further investigation showed decreased
mitochondrial antiviral-signaling protein (MAVS) level, natural
killer (NK) cell activity and T cell activity in stressed mice,
indicating significant impairment of both innate and adaptive
immunity42,45,46. TCM formulas, such as KangBingDu Oral Liqid,
are able to reverse the stress effects and reduce host susceptibility
to virus, furtherly proving the feasibility to apply TCM in viral
infection42,44. Chronic psychological stress is able to inhibit innateincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
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+ MODELand adaptive immune response towards HSV-1 including NK cell
activity, HSV-specific CD8þ T cell number and activity, immunity
related cytokine level and lymphocyte infiltration35. Restraint
stress prolongs the length of HSV-1 infection and increases the
number of infected neurons, resulting in longer viral progeny and
more severe recurrent lesions47. Based on the unpublished data we
obtained, using corticosterone (CORT) stress model in normal and
glucocorticoid receptor (GR) knocked-down SH-SY5Y cells, as
well as restraint-stressed mice models, we have confirmed that
stress hormone CORT can enhance HSV-1 susceptibility, and that
such increase is largely dependent on GR. Our results further
demonstrated that the GR-dependent effect of CORT on HSV-1
susceptibility is related to the inhibition of interferon regulatory
factor 3 (IRF3) phosphorylation and the decrease of IFN-b,
indicating an inhibitory effect of GR on innate immunity (Fig. 2).
Interestingly, it has been found that, different from chronic psy-
chological stress and restraint stress, social disruption stress can
enhance the innate immune responsed to a primary HSV-1
infection in both cornea and TG of mice by increasedFigure 2 CORT enhances HSV-1 susceptibility, inhibits innate immu
illustration of the effect of CORT on HSV-1 susceptibility. (B) SH-SY5Y
groups). One day after the transfection, the cells were pretreated with CORT
In the NC groups, CORT induced significant increase in viral protein GB
groups, the effect of CORT was attenuated. These results indicate that s
indispensable for its effect, and such effect is related to innate immunity. (C
increased the susceptibility of SH-SY5Y to HSV-1. High dose of GR antag
antagonist RU486. Significances were marked as **P < 0.01 vs. virus grou
stress showed more serious HSK phenotype than the unstressed group. R
shown in this figure are unpublished data of our group.
Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.expression of anti-viral cytokines and infiltration of macrophages,
ultimately reducing the severity and frequency of future re-
currences48. Under HSV-1 infection, tripartite motif-containing 14
(TRIM14) is likely to cleave the ubiquitin chain of cyclic GMP-
AMP synthase (cGAS) and prevent it from being degraded
through autophagy, ultimately enhancing IFN signaling, thus
improving immune responses49.
Besides innate and adaptive immunity, another currently under
researched immunity, intrinsic immunity is closely related to the
defense against HSV-1 invasion. To some extent, intrinsic im-
munity might play a more important role in neurons than in other
cells50. Evidence also shown that neuronal cells are less respon-
sive to IFN signaling than other types of cells51. As far as we
know, there are three components for host intrinsic defense against
HSV-1: autophagy, HSV-1 repressive complex and nuclear do-
mains 10 (ND10) nuclear bodies50. As the virus enter the neuron,
virions are degraded through xenophagy activated by pathogen-
associated molecular patterns (PAMPs), damage-associated mo-
lecular patterns (DAMPs) and pattern-recognition receptorsnity and GR knock-down attenuates the effect. (A) The schematic
cells were transfected with vectors (NC groups) or GR siRNA (Si-GR
for 48 h and then inoculated with HSV-1 F strain (MOIZ 1) for 24 h.
and decrease in IFN-b and phosphorylated IRF3, while in the Si-GR
tress hormone CORT is able to enhance HSV-1 susceptibility. GR is
) Flow cytometry results show that pretreatment of CORT significantly
onist RU486 significantly attenuated the effect of CORT. GR-Ant, GR
p and #P < 0.05 vs. CORTþvirus group. (D) Mice loaded with restraint
U486 alleviated the symptom. GR-Ant, GR antagonist RU486. Data
increases the susceptibility to primary and recurrent infections of herpes
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+ MODEL(PRRs). During virus replication, viral DNA and proteins are
recognized and degraded through autophagy51,52. Autophagy may
also be induced by IFN-b during HSV-1 replication53. The
increased cGAS mentioned earlier is reported to interact with
beclin-1, contributing to the autophagy of viral DNA54. HSV-1 has
evolved a confrontational mechanism to counter host autophagic
defense through a viral protein, infected cell polypeptide 34.5
(ICP34.5)55e60. It is well understood that autophagy is enhanced
under stress61,62. On the one hand, enhanced autophagy may
improve the intrinsic defense against HSV-157; on the other hand,
however, the increased autophagy may also prolong host cell
survival and provide a more advantageous environment for HSV-1
replication63. Besides, whether stress-induced autophagy has the
same virus clearance effect as xenophagy, a selective autophagy,
remains unknown. Moreover, stress-induced autophagy upregu-
lation might increase the degradation of cGAS, casing a loss of
IFN signaling49. Therefore, the exact fate of HSV-1 susceptibility
under stress-induced autophagy enhancement requires further
investigation. The conflict between the facts that stress increases
HSV-1 susceptibility and that stress enhances autophagy suggests
more complicated mechanisms for stress-induced susceptibility.
One possible explanation is that stress-induced autophagy in-
creases the degradation of intrinsic defense components, such as
promyelocytic leukemia protein (PML) in ND10 nuclear bodies,
and hence defecting the intrinsic immune response, which is
especially essential for the defense against HSV-1 infection64.
Therefore, the stress-induced autophagy of intrinsic immune
components may be a possible research direction in the future.
3. The YineYang balance between HSV-1 and host cell
defense: the establishment and maintenance of latency
HSV-1 is characterized by establishing latency as a non-
integrated, nucleosome-associated episome in neuronal nuclei.
In the process of latency establishment, new sets of Yin factors
and Yang factors counteract, transform, and ultimately reach a
new YineYang balance between the virus and the host. When the
new homeostatic YineYang balance is created, the virus enters its
latent state in which it resides relatively silently in the nucleus of
the infected cells without producing infectious viral progeny. It is
hypothesized that neuronal latency is the result of a failure to
initiate the lytic cascade, which might be determined by the
distinctive architecture of neurons. Therefore, here we introduce
the molecular process of normal HSV-1 lytic infection process and
illustrate how latency is established. The initiation of IE genes,
specifically, ICP0, is the essential trigger for the following
expression of E and L genes, indispensable for HSV-1 lytic
infection65. Therefore, triggering IE gene expression would be
crucial for entering lytic infection. With the cooperation of lysine-
specific demethylase 1 (LSD1), the viral protein VP16 recruit
octamer binding protein 1 (OCT1) and host cell factor 1 (HCF1)
in order to form enough OCT-1/HCF-1/VP16 triplets. The triplets
then bind to IE gene promoters and activate IE gene transcrip-
tion66. ICP0 can then replace the histone deacetylases (HDACs) in
the HDAC/RE1-silencing transcription factor (REST)/REST
corepressor 1 (CoREST)/LSD1 repressor complex, after which the
previously suppressed E and L gene expression can be triggered67.
Only with enough VP16 entering the nucleus can HSV-1 suc-
cessfully enter its lytic phase. However, specific characteristics of
neurons make it especially suitable for HSV-1 to establish latency.
The other two ingredients in the triplet tend to distribute differ-
ently in neurons, compared with other cells. HCF1 is morePlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.abundant in the cytoplasm than in the nucleus in unstressed neu-
rons, while at the same time, OCT-1 is downregulated in neurons;
both lead to less VP16 in the nucleus68. The HSV-1 genome is also
closely associated with ND10 nuclear bodies, which consists of
main components like PML, death-domain associated protein
(Daxx) and SP100 nuclear antigen69. Under the stimulation of
IFNs, they are able to bind closely to HSV-1 genome and inhibit
its lytic replication70. However, such defense is also countered by
viral protein ICP0, which possesses the activity of E3 ubiquitin
ligase64.
In fact, the number of viral particles that infect axons is
another factor to determine whether the virus enter latency or not.
The viral genome was silenced below a threshold multiplicity of
infection (MOI) of 0.1; while high MOI infection resulted in
productive infections71. To sum up, the special characteristics of
neurons which are able to prevent the initiation of the viral lytic
cascade and reduce the number of virions from the axons are the
two important factors for the establishment of neuronal latency.
In contrast, immune surveillance seems to be dispensable for
the establishment of viral latency, though the system is also crit-
ical for the early control of viral distribution as well as elimination
of the replication of virus. Mice that lack the innate and adaptive
immune system are still able to establish HSV-1 latency in TG72.
Furthermore, HSV-1 latency can be established in the absence of
neuronal IFN signaling73. Evidence in rabbit model showed that
latency-associated transcripts (LATs) are able to enhance latency
establishment74, which indicates that LAT participate in the
establishment of the latent state. However, since latency is still
able to establish in the absence of it, and that it also accumulates
in productively infected cells post-infection, LAT may not be
crucial for latency establishment75.
Whether HSV-1 can establish non-neuronal latency is unclear.
However, there are several publications on cornea latent infection,
suggesting that the cornea might be a possible site of latency76.
There were evidences indicating the potential of HSV-1 latent
infection in the human cornea early in the 90s77,78. Further studies
have shown that HSV-1 DNA can be present in human corneas
even though ocular herpetic disease has not been found in the
corneas from animal models including mice79e82 and nonhuman
primates83. These results are consistent with the findings in rab-
bits, i.e., the retrograde migration of HSV-1 DNA occurs from the
transplanted corneas of rabbits latently infected with LAT positive
HSV-1 to the uninfected rabbits following transcorneal epineph-
rine iontophoresis75. In addition, LAT was found in the human
cornea80, but no other transcriptional products (RNA) or expres-
sion products (protein) were observed. Given the lack of such
observations, HSV-1 latency in the cornea is still disputed, i.e., if
the virus is truly latent in the cornea or only at a transition point
along the exit path from a sensory ganglion. So far, there are three
hypotheses for the presence of this DNA in human corneas: (i)
operational latency; (ii) a low persistent infection in the cornea
and (iii) reactivation from neuronal sites. Hence, operational la-
tency in the cornea is very likely to be dependent on novel
detection methods, which is more sensitive than present virus
detection methods84.
Maintenance of viral latency is dependent on the delicate
YineYang balance maintained between HSV-1 and the synergistic
effects of several host factors: immunity, HSV-1 microRNAs and
other factors (Fig. 3). In this context, Yang is the virus-stimulating
factors, including HSV-1 virus itself, promoted glucocorticoid
level, oxidational damages, etc.; Yin is the virus-inhibiting factors,
such as immunity, thyroid hormone level, etc. The currently mostincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Figure 3 The interaction between HSV-1 and host cell defense during latency. During latency, HSV-1 activity is inhibited by multiple factors.
Intrinsic, innate and adaptive immunity supervise HSV-1 replication while modulating each other. Intrinsic immunity inhibits HSV-1 activity
mainly through ND10 nuclear body, autophagy and HDAC/CoREST/LSD1/REST repressor complex, and HSV-1 acts against them through the
effect of ICP0 and ICP34.5. Adaptive and innate immunity inhibit the viral activity through granzyme B and IFN-g secretion, leading to host cell
apoptosis. Excretion of NGF by neurons inhibits HSV-1 activity. During latency, HSV-1 only expresses LAT-derived miRNAs, which are able to
inhibit lytic gene expressions.
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+ MODELfrequently used antiviral treatments for HSV-1 are DNA poly-
merase inhibitors including acyclovir, famciclovir, and valaciclo-
vir85,86. Attenuated mutations of HSV-1 lower the virulence by
deletion of ICP087, deletion of ICP34.588, expression of ICP34.5
complementary miRNAs89, etc. They both act as interventions of
the Yang, which attenuate the Yang factors in the YineYang
balance and facilitate the maintenance of latency. When the or-
ganism experiences stress stimulation, the balance will be inter-
rupted, ultimately leading to reactivation.
During latency, viral gene expression is largely suppressed
except for the abundant expression of LATs and other non-coding
RNAs. LAT and its associated miRNA species have been found to
influence viral maintenance by suppressing HSV-1 gene expres-
sion in vivo and in vitro90e92. In murine ganglia latently infected
by LAT-mutant HSV-1, both the neurovirulence and reactivation
frequency are significantly increased93 and the latency is
impaired94, providing further clues for the role of LAT in latency
maintenance.
In addition to repressing virus-encoded gene expression, LAT
can promote neuronal cell survival by inhibiting apoptosis95,
which may contribute to maintaining the latency and increasing
the survival of the virus in the host. LAT’s anti-apoptotic function
is mediated through multiple ways. On one hand, cells are pro-
tected against cold-shock-induced apoptosis mainly by preventing
the dephosphorylation of protein kinase B (AKT), a serine/thre-
onine protein kinase promoting cell survival96. On the other hand,
LAT expressing plasmids are able to inhibit the two major
apoptosis pathways in mammals induced by caspase-8, caspase-9,Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.and caspase-397e99. LAT can prevent infected neurons from being
killed by CD8þ T cells through anti-apoptosis activity98.
A set of miRNAs derived from LAT are able to target viral
transcripts and inhibit HSV-1 gene expression100. HSV-1-miR-H6
can target ICP4 mRNA, inhibiting the expression of the tran-
scription factor crucial to E and L gene transcription, blocking
virus lytic infection and decreasing IL-6 expression, hence pro-
moting HSV-1 latency101,102. HSV-1-miR-H2, which has been
associated with the regulation of latency, binds to viral ICP0
mRNA and inhibits its expression. ICP0 plays a major role in both
primary and recurrent HSV-1 infections. Its expression triggers the
entry of HSV-1 into the replication cycle93,103. HSV1-miR-H4
inhibits the expression of the viral ICP34.5 gene, an important
lytic neurovirulence factor indispensable for promoting viral
spread from TG cells to non-neuronal cells89,104,105. Two small
non-coding RNAs (sncRNAs) derived from LAT also contribute to
the decrease of lytic gene expression and apoptosis
inhibition91,106.
Another strategy employed by HSV-1 is to activate cellular
glucose synthesis and glycolysis, in order to increase available
energy for virus survival107. The activation of AMP-dependent
kinase (AMPK) and sirtuin 1 (SIRT1) pathways is effective in
inhibiting productive infection and protecting cells from virus
related damage108. The modulation of AMPK/SIRT1 axis is
modulated over time to suit the HSV-1 infection process109. An
over-expression of Luman/CREB3 recruitment factor (LRF), acts
as a repressor in a direct or indirect manner to inhibit essential
genes of HSV-1 lytic infection110.increases the susceptibility to primary and recurrent infections of herpes
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+ MODELFurthermore, different cytokines have different abilities to
support latency and suppress lytic HSV-1 replication, providing a
fundamental-level control based on neuronevirus interaction111.
IFN-b can achieve control of the infection by enhancing the
restriction of HSV-1 replication in neuronal cells104. IFN-b
regulates LAT expression, which has a positive effect on neuron
survival73. Nerve growth factor (NGF)-responsive receptors and
signal transduction pathways are necessary to maintain latency
and prevent reactivation. This is consistent with the ability of
HSV-1 to establish latency in primary sympathetic neurons and
Nd-PC12 cells cultured in the presence of NGF112,113. NGF
ablation can induce HSV-1 reactivation in sensory and sympa-
thetic neurons in vitro or after anti-NGF treatment in vivo114.
Moreover, neurons infected with latent HSV-1 experience reac-
tivation in the presence of antibodies to NGF115. The ability of
NGF to maintain latency has also been proven when herpetic
keratitis was topically treated with NGF116. It turns out that the
activation of pyruvate dehydrogenase lipoamide kinase isozyme
1 (PDK1) caused by the reaction of NGF with tropomyosin re-
ceptor kinase A (TRKA) is the dominant pathway of NGF to
suppress reactivation. Suppression of phosphoinositide 3-kinases
(PI3Ks) induces HSV-1 reactivation and activation of AKT, the
key component for PI3K pathway, which is particularly critical
for the maintenance of latency111,117. This effect of NGF is
closely related to mammalian target of rapamycin (mTOR), an
important factor in the PI3K/AKT pathway, which controls the
population of mRNAs that are actively translated into proteins.
These proteins suppress the lytic cycle by sustaining the
repressive chromatin state of the viral genome through activating
eIF4E-binding protein (4E-BP)118.
During latency, the viral genome associates with nucleosomes
by chromatin remodeling. Histone post-translational modifica-
tions (PTMs) representative of euchromatin and heterochromatin
are found on HSV-1 genes during latency. As a result, the
regulation of latent gene expression exists at the level of epige-
netic modification. Two activating euchromatin-like modifica-
tions that commonly define areas of euchromatin are acetylation
of histone H3 on lysines 9 and 14 (H3K9, K14) and dimethyla-
tion of histone H3 on lysine 4 (H3K4). Indeed, during lytic
infection, acetylation of H3K9 and H3K14 are enriched upon
lytic gene promoters; while repressive heterochromatin-like
modifications are under-represented119. In contrast, during la-
tency, the actively transcribed LAT locus become enriched in
acetylated H3K9 and H3K14 at the LAT promoter and enhancer,
while these modified histones are absent at the ICP0 promoter or
DNA polymerase gene120. Meanwhile, viral lytic genes are
enriched with repressive heterochromatin-like modifications such
as methylated H3K27 and methylated H3K9. These observations
correspond with latency feature that the LAT is abundant whilst
lytic genes are silent. Furthermore, while HDAC inhibitors
induce reactivation in latently infected mice121, inhibitors of
LSD1 activities that can specifically block demethylation of the
repressive markers, such as H3K9me3, H3K9me2 and
H3K27me3, will enhance the epigenetic suppression of the viral
genome and reduce the reactivation in cultured neurons122. In
order to prevent the spread of heterochromatin into areas of
euchromatin, there must be barriers in place to keep these do-
mains separate. CCCTC-binding factor (CTCF), a transcriptional
repressor, can bind to the sites in HSV-1 genome as boundary
elements123. Thus, the transcriptionally active LAT promoter
regions will be segregated from the repressed regions of the
genome and the LAT enhancer will be prevented from acting onPlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.the surrounding lytic genes124. These findings have suggested
that epigenetic regulation may control the switch between la-
tency and reactivation.
Systemically, HSV-1 latent infection is surveyed by the im-
mune system through the cooperation of tissue cells and immune
cells including CD4þ and CD8þ T lymphocytes. These HSV-1
specific T cells belong to tissue resident memory T (TRM) cells.
They have a longer lifespan than normal T cells, and establish a
long-term residence in TG125. During latency, the lytic genome of
HSV-1 is not completely silenced. Instead, limited lytic gene
expression is frequently recognized by MHC class I molecules
expressing cells, CD4þ and CD8þ T cells126. For example, local
expression of viral proteins such as ICP6 and VP16 is recognized
by TG-resident CD4þ and CD8þ T cells127. These facts have
indicated that HSV-1 latency maintenance involves active identi-
fication and response for viral gene by host immune system. In
TG, both HSV-1 specific and non-specific CD8þ T cells exist and
cooperate with each other, contributing to the control of la-
tency128. When HSV-1 lytic gene expresses at a relatively low
level, non-specific CD8þ T cells can inhibit the reactivation
through inhibiting ICP0 by IFN-g. A novel autophagic response
has been discovered, which is related to the IFN signaling in TG53.
For neurons that are refractory to IFN-g, the HSV-1 specific CD8þ
T cells can excrete granzyme B to degrade ICP4, and then block
viral gene expression129.
The research on HSV-1-specific CD8þ T cells is particularly
comprehensive. These cells have been shown important for la-
tency maintenance130, and the reactivation can be reduced by
broadening the repertoire of HSV-1 specific T cell that is resident
in TG131. The receptor activator of NF-kB ligands (RANKL) has
the control over the induction of TG-resident CD8þ T cells. The
activation of RANKL also prevents cell apoptosis132. The bal-
ance between the survey of TG-resident HSV-1 specific CD8þ T
cells and their exhaustion monitored by HSV-1 LAT gene is
important for the maintenance of latent status133. Though CD4þ
T cells do not have direct effect on latency maintenance, they can
perform an indirect function to prevent partial CD8þ T cell
exhaustion134. Recently, it has been discovered that CD8aþ
dendritic cells (DCs) play a more crucial role in latency main-
tenance than CD8þ T cells135. Moreover, CD8aþ DCs are
influential in T cell exhaustion, which contributes to latency
maintenance136.
4. Stress disrupts the YineYang balance and causes
reactivation
When the YineYang balance maintained in latency is disrupted by
stress, HSV-1 enters its reactivation cycle and causes recurrent
diseases (Fig. 4). Stress induces the reactivation of latent HSV-1
through multiple mechanisms. When the stress is removed, the
latency will be re-established due to the re-silenced viral
genome137. Through investigations on previous researches, we
summarized the molecular mechanisms in HSV-1 latency estab-
lishment, maintenance and reactivation in Fig. 5. Getting through
the barriers of host immunity, HSV-1 virions enter the cell and
some of them are degraded via xenophagy. During latency, the
lytic genes are inhibited by chromosomal modifications, LAT-
derived miRNAs, intrinsic, adaptive and innate immunity. Under
psychological stress or hyperthermia, the increased glucocorti-
coids trigger reactivation by either directly activating the virus
through GR activation or indirectly affecting host immunity.
Under UV stress or physical trauma, ROS level increases, causingincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Figure 4 Stress disturbs the YineYang balance between HSV-1 stimulating and inhibiting factors. During HSV-1 latent infection, the HSV-1
stimulating and inhibiting factors form a delicate YineYang balance. Yin factors include virus inhibiting factors such as thyroid hormone,
chromosomal modification, host immunity and LAT; Yang factors are the virus stimulating factors like ROS, glucocorticoids, SGKs, KLF15, and
ICP0. When the host experiences stress stimulation, for instance, psychological stress, the Yin factors are inhibited and the Yang factors are
promoted. Hence the balance is disturbed, which ultimately leads to recurrent lesions.
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+ MODELoxidational damage, hence inducing the reactivation. As we pre-
viously described in our publications, we have developed a suc-
cessful disease susceptibility model, restraint-stressed mice
model, to simulate the effects of stress on virus
infection39e46,138,139. Hence, restraint-stress mice model can be a
feasible model for stress-induced HSV-1 reactivation, as illus-
trated in Fig. 6.
4.1. Stress induces hormonal changes
It is well established that stress-induced changes of hormones
such as glucocorticoids and thyroid hormone can stimulate
HSV-1140,141 and drive reactivation from latency (Fig. 7). Stress,
e.g., psychological stress and hyperthermia, can activate the
hypothalamoepituitaryeadrenal (HPA) axis142 and increase the
concentration of glucocorticoids in the blood143. Glucocorticoids
induce HSV-1 reactivation mainly through two distinct pro-
cesses: directly affecting HSV-1 virus and indirectly promoting
reactivation. Glucocorticoids activate GRs and directly activate
HSV-1 transcription by interacting with the GR response ele-
ments (GREs) on virus genome. A recent study showed that when
cells are treated with synthetic corticosteroid dexamethasone
(DEX), GR and Kru¨ppel-like transcription factor 15 (KLF15)
cooperate to stimulate reactivation through the transactivation of
ICP0144. Serum and glucocorticoid-regulated protein kinases
(SGKs) has been reported to increase after stress stimulation and
participate in HSV-1 reactivation from latency145. The increased
glucocorticoid level also affects both intrinsic and adaptive im-
munities. TG-resident HSV-1-specific CD8þ T cells are reduced
and those survived CD8þ T cells compromise functionally,
which induces HSV-1 reactivation for compromising CD8þ T
cell surveillance. The impairment of CD8þ T cells may occur via
affecting GRs on DCs that are responsible for priming these
HSV-1 specific T cells36,146. Interestingly, however, psycholog-
ical stress might not diminish CD8þ T cells via impairing DCs.
Instead, it could be due to the decrease of T cell stimulative
cytokines such as IFN-g and IL-2149. Further effects of gluco-
corticoid upregulation by stress are significantly reduced con-
centrations of granzyme B and IFN-g142,146,147. Also, stress has
been proven to cause mitochondrial damage and to decrease
MAVS expression45. It can decrease NK cell activity inPlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.individuals that are latently infected with HSV-1, which might be
due to the reduction of IFN-g and IL-2148.
Thyroid hormone (T3) is able to cause strong suppression of
HSV-1 replication149. T3 can activate LAT and consequently
repress ICP0 expression150. It also has repressive effect on the
HSV-1 thymidine kinase (TK ) gene, which is important for viral
reactivation149. Psychological stress inhibits the hypothal-
amicepituitaryethyroid (HPT) axis and leads to the reduction in
T3 secretion. Hence, with the decrease of T3 and the reduction in
its suppression effects, there is an increase of ICP0 expression. It
has been shown that the overexpression of thyroid receptor b1 can
enhance LAT transcription and recruit H3K9me3 and H3K9me2
to repress the TK gene, leading to an increased virus suppression
efficiency. In addition, TG neurons overexpressed with thyroid
receptor b1 were less susceptive to the reactivation induced by T3
decrease151. However, it should be noted that the suppression ef-
fect of T3 only works on neuronal cells, and differential conden-
sation of chromosome may be important in this process152. T3 also
regulates the expression of dynein and modify neuronal
outgrowth, suggesting the specific role T3 plays in viral transport
and anti-apoptosis153.
4.2. Stress reverses chromosomal modification
Under stress, the chromosomal modifications on HSV-1 lytic
DNA might be reversed and viral DNA expression might be
modified, which lead to induction of lytic replication107. This
hypothesis has been supported by a number of studies, which
have found that chromatin remodeling around the LAT region
and surrounding lytic genes is likely to occurs after a stress
stimulus154,155. Loss of CTCF proteins from chromosomal in-
sulators through stress-induced phosphorylation increased the
accessibility of viral genes for transcriptional activation.
Replacement of demethylation of H3K27 on lytic genes with
euchromatin that is triggered by displacing protein regulator of
cytokinesis 1 (PRC1) complexes has been reported to have the
similar function124. As a result, the lytic genes would produc-
tively express and eventually reactivate.
In fact, a number of transient chromatin modification have
been discussed. It has been suggested that histone H3 at serine 10
undergoes a methyl/phospho switch during the first phase ofincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Figure 5 Molecular mechanism in an HSV-1-infected neuron during latency establishment, maintenance and reactivation. When HSV-1 virus
enters the cell, some virions are degraded through xenophagy. HSV-1 tends to enter latency in unstressed neurons. During latency, HSV-1 DNA
remains in its latent phase, CTCFs are attached to the insulators, and the major transcription product of IRL gene is LAT. LAT-derived miRNAs are
able to inhibit lytic gene expression. PRC1 complexes are also attached to the genome, suggesting possible inhibitory effect. The HDAC/CoREST/
LSD1/REST repressor complex is in its default state to suppress the expression of E and L genes. CD8þ T cells release IFN-g, granzyme B and
caspases into the neuron, and NK cells release granzyme B. IFN-g inhibits the expression of ICP0, granzyme B inhibits the expression of ICP4,
and miRNAs are able to inhibit the expressions of ICP0, ICP4 and ICP34.5. Neuron itself induces NGF which also inhibits reactivation. Psy-
chological stress and hyperthermia increase the level of glucocorticoids, inhibiting the activity of immune cells. Glucocorticoids are also able to
bind to glucocorticoid receptors and activate HSV-1 by inducing and cooperating with KLF15, thereby activating ICP0 transcription. UV and
physical trauma increase ROS level. All these stress factors wake up the HSV-1 genome and lead to reactivation. During reactivation, PRC1
complexes are replaced, all CTCFs are evicted from the insulators. Consequently, the lytic genes are able to transcribe and the transcripts of IRL
gene yield ICP0 and ICP4. ICP0 then removes HDAC from the HDAC/CoREST/LSD1/REST repressor complex, stimulating the expression of all
lytic genes, leading to the complete reactivation of viral genome. Some of the newly synthesized viral DNA and protein components are degraded
through autophagy.
Stress increases the susceptibility to HSV-1 primary and recurrent infections 9
+ MODELreactivation, and activation of lytic genes is achieved without the
removal of H3K9me3156. It is then followed by VP16 synthesis in
the second phase157. When the VP16 promotor is activated, in the
absence of other lytic viral gene expressions, the expression of
VP16 leads to the exit of latency and the entry of lytic cycle158.Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.Therefore, modification of VP16 is required for reactivation of
HSV-1 in neuronal cells159. Administration of an inhibitor for
helicase-primase is able to suppress such reactivation, which
suggests the chromatin modification mentioned above to be
essential160.increases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Figure 6 Illustration of restraint stress causing recurrent lesions in mice latently infected with HSV-1. Inoculated with HSV-1 through corneal
scratches, the mice were kept under adequate condition for 4e5 weeks to establish latency. When the establishment of latency was confirmed in
trigeminal ganglia via virus titration measurement, the LAT expression of uninfected and infected groups were tested. Plaque assay showed no
detectable productive HSV-1 progeny. The latently infected mice were then loaded with restraint stress, and the phenotype was assessed afterward.
Data shown in this figure are unpublished data of our group.
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+ MODEL4.3. Stress causes oxidational damage and induces apoptosis
Under UV or physical trauma, dendrite mitochondria produce
reactive oxygen species (ROS) to inhibit mTOR activity and
decrease the expression of B-cell lymphoma 2 (BCL-2), inducing
apoptosis161. In order to escape from the soon to be apoptotic
cells, HSV-1 spreads among host cells in an attempt to infect new
individuals. All viral gene classes will be expressed at the same
time and enter full reactivation, followed by the infection of pe-
ripheral epithelial and neuronal cells to remain the survival andPlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.spread of HSV-1162. HSV-1 itself may also be a stimulant to
apoptosis. HSV-1 protein ICP27 can increase host cell suscepti-
bility to apoptosis, which is also probably through the production
of higher level of ROS163.
5. Discussion and perspective
With the astonishingly rapid development of industrialization and
economics in modern society, people have suffered much more
stress caused by the environmental, psychological and physicalincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Figure 7 Stress-induced hormone imbalance which leads to reactivation. Psychological stress acts on hypothalamus, stimulates HPA axis
(purple arrows) and suppresses HPT axis (blue arrows). In HPA axis, CRH released by hypothalamus increases, enhancing the ACTH released by
pituitary gland. As the ACTH level increases, glucocorticoid excreted by adrenal gland also increases. The increased glucocorticoid then activates
GRs, activating the transcription of lytic gene ICP0. It also inhibits DC activity, causing the reduction of TG-resident HSV-specific CD8þ T cell
activity, affecting adaptive immunity towards HSV-1. Since glucocorticoid is able to inhibit granzyme B and IFN-g secretion, the granzyme B and
IFN-g level are reduced significantly, which causes the decrease of NK cell activity, affecting innate immunity towards HSV-1. In HPT axis, TRH
released by hypothalamus decreases, reducing TSH released by pituitary gland. Thyroid gland then reduces the excretion of T3, which decreases
the LAT transcription activated by T3. The suppressive effect of LAT to ICP0 transcription is weakened, and the increased ICP0 level enhances
lytic gene transcription. The suppressive effect of T3 towards TK gene, an important viral gene for HSV-1 reactivation, is also decreased.
Overexpressed TR1 receptor is able to increase the effect of T3, reversing the changes caused by the reduction of T3.
Stress increases the susceptibility to HSV-1 primary and recurrent infections 11
+ MODELfactors. Stress, especially psychological stress caused by
emotional stimulation, is able to increase the susceptibility and
severity of infectious diseases and to cause the reactivation from
latency, leading to disturbance on life quality. Therefore, reducing
the effect of stress on diseases is becoming an urgent and widely
concerned topic. Emotional stress causes internal damage called
“Qi-Qing Nei-Shang” and consequently disturbs the YineYang
balance in the organism, leading to increased susceptibility to
HSV-1 and the recurrent lesions. Nevertheless, how emotional
stimulation affects the biological pattern and the nature of HSV-1
reactivation susceptibility still needs further systematic study.
Moreover, considering that once an individual is infected, noPlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.treatment exists to remove the HSV-1 virus completely from the
host, an approach to control latent infection and reduce reac-
tivation becomes the crux of the issue.
In conclusion, it has been well-known that followed by the
invasion of HSV-1 into the neurons, the virus travels through
microtubules into the nucleus, where most of the HSV-1 genome
is silenced due to the specific characteristics of neurons. However,
the virus can still function properly to avoid the detection of im-
mune system. Neuronal factors have contributed to the anti-
apoptosis effect and facilitated the survival of infected cells.
Epigenetic modification and the direct effect of latent gene can
reduce lytic gene expression, and thus the virus cannot be detectedincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
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+ MODELby the immune system. The virus can also deplete T cells to
reduce the survey intensity. The YineYang balance between the
virus-stimulating and virus-inhibiting factors maintains the la-
tency. Under stress, oxidational damage, increased glucocorticoids
and decreased thyroid hormones promote the Yang factors and
inhibit the Yin factors, consequently disturbing the YineYang
balance, leading to productive viral replication.
However, several obstacles remain in the way towards more
specific, accurate and coherent understanding of HSV-1 latency
and reactivation. Current major animal and cellular models are not
sufficient to unravel the mechanistic details. Models of closer
genetic similarity with human, e.g., Rhesus macaques, and newly
developed models like tree shrews may be more adequate models
to study HSV-1 latency and reactivation4,164. In addition, we still
know very little about the molecular mechanism of other stress
hormones such as epinephrine, growth hormone and prolac-
tin33,165. More investigations on other stress hormones are
required for a better overall understanding on stress and HSV-1
reactivation. Additionally, according to a research by Edgar
et al166, herpes virus infection is enhanced under circadian clock
disruption stress, suggesting a new possible direction on how
stress influences the susceptibility of HSV-1 infection. According
to our current understanding on the role of stress in HSV-1
infection and the instruction of TCM theory, many small mole-
cules with potential anti-HSV-1 activity have been discovered
from TCMs. We have recently published a review specifically
focusing on the anti-HSV-1 small molecules originated from
different TCMs, and their pharmacodynamics mechanisms167.
Therein, three main mechanisms were discussed, including auto-
phagy regulation, immunity enhancement, and inhibition of
HSV-1 virus replication and infection processes. Numerous
sources, e.g., Lychee flower, Houttuynia cordata, and Curcuma
longa L., and their effect corresponding mechanisms were dis-
cussed in detail. They are promising drug candidates for novel
treatments to prevent stress-induced susceptibility to HSV-1 and
the following recurrent diseases. Furthermore, the combination of
YineYang theory and modern molecular biology may create novel
perspectives and approaches in new drug discovery and treatment
development. Both Yin and Yang factors we demonstrated above
are possible targets for anti-HSV-1 drug and treatment develop-
ment, e.g., the enhancement of Yin factors including HSV-1-
specific miRNAs, thyroid receptor b1, and ND10 nuclear
bodies, and the inhibition of Yang factors including the expression
of glucocorticoids, the cooperation of GR and KLF15, the activity
of SGKs, the expression of ICP0 and ICP34.5. More systematic
researches based on YineYang theory and other TCM theories,
combined with genomics, proteomics, metabolomics, high
throughput in silico screening, etc., may be available approaches
to unlock the treasure house of TCM therapy against HSV-
1168e170. Further detailed explorations are required for a more
thorough understanding of stress-induced HSV-1 susceptibility
and reactivation and feasible treatments.Acknowledgments
This work was supported, in part, by the National Key Research
and Development Program of China, China (grant number
2017YFC1700404); Natural Science Foundation of China, China
(grant numbers 81622050, 81573675, 81673709, 81560661 and
81873209); the Young Top-notch Talent Support Program of
Guangdong Province, China (grant numbers 2014TQ01R229 andPlease cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.2016TQ03R586); Guangdong Province Ocean and Fisheries Bu-
reau-Key Technology Research and Development Program, China
(grant number A201701A02); Guangdong Science and Technol-
ogy Foundation for Distinguished Young Scholars, China (grant
number 2017A030306004) and the Science and Technology Pro-
gram of Guangzhou, China (grant numbers 201604046016 and
201610010182).References
1. Kumar SP, Chandy ML, Shanavas M, Khan S, Suresh KV. Patho-
genesis and life cycle of herpes simplex virus infection-stages of
primary, latency and recurrence. J Oral Maxillofac Surg Med Pathol
2016;28:350e3.
2. Bigley NJ. Complexity of interferon-gamma interactions with HSV-
1. Front Immunol 2014;5:15.
3. Antinone SE, Zaichick SV, Smith GA. Resolving the assembly state
of herpes simplex virus during axon transport by live-cell imaging. J
Virol 2010;84:13019e30.
4. Li L, Li Z, Wang E, Yang R, Xiao Y, Han H, et al. Herpes simplex
virus 1 infection of tree shrews differs from that of mice in the
severity of acute infection and viral transcription in the peripheral
nervous system. J Virol 2015;90:790e804.
5. Bernstein DI, Bellamy AR, Hook 3rd EW, Levin MJ, Wald A,
Ewell MG, et al. Epidemiology, clinical presentation, and antibody
response to primary infection with herpes simplex virus type 1 and
type 2 in young women. Clin Infect Dis 2013;56:344e51.
6. Shen JH, Huang KYA, Chen CY, Chen CJ, Lin TY, Huang YC.
Seroprevalence of herpes simplex virus type 1 and 2 in Taiwan and
risk factor analysis, 2007. PLoS One 2015;10. e0134178.
7. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seropreva-
lence of herpes simplex virus types 1 and 2dUnited States, 1999-
2010. J Infect Dis 2014;209:325e33.
8. Vilibic-Cavlek T, Kolaric B, Ljubin-Sternak S, Mlinaric-Galinovic G.
Herpes simplex virus infection in the Croatian population. Scand J
Infect Dis 2011;43:918e22.
9. Lin H, He N, Su M, Feng J, Chen L, Gao M. Herpes simplex virus
infections among rural residents in eastern China. BMC Infect Dis
2011;11:69.
10. Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A.
Prevalence of infection with herpes simplex virus types 1 and 2 in
Australia: a nationwide population based survey. Sex Transm Infect
2006;82:164e8.
11. Levett PN. Seroprevalence of HSV-1 and HSV-2 in Barbados. Med
Microbiol Immunol 2005;194:105e7.
12. Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L,
et al. Current management and recommendations for access to
antiviral therapy of herpes labialis. J Clin Virol 2012;53:6e11.
13. Kolokotronis A, Doumas S. Herpes simplex virus infection, with
particular reference to the progression and complications of primary
herpetic gingivostomatitis. Clin Microbiol Infect 2006;12:202e11.
14. Bussmann C, Peng WM, Bieber T, Novak N. Molecular pathogenesis
and clinical implications of eczema herpeticum. Expert Rev Mol Med
2008;10:e21.
15. Whitley RJ. Herpes simplex encephalitis: adolescents and adults.
Antivir Res 2006;71:141e8.
16. Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses:
herpes simplex and varicella-zoster. Lancet Neurol 2007;6:1015e28.
17. Perlejewski K, Popiel M, Laskus T, Nakamura S, Motooka D,
Stokowy T, et al. Next-generation sequencing (NGS) in the identi-
fication of encephalitis-causing viruses: unexpected detection of
human herpesvirus 1 while searching for RNA pathogens. J Virol
Methods 2015;226:1e6.
18. Shimomura Y. Herpes simplex virus latency, reactivation, and a new
antiviral therapy for herpetic keratitis. Nippon Ganka Gakkai Zasshi
2008;112:247e64.increases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Stress increases the susceptibility to HSV-1 primary and recurrent infections 13
+ MODEL19. Toma HS, Murina AT, Areaux Jr RG, Neumann DM,
Bhattacharjee PS, Foster TP, et al. Ocular HSV-1 latency, reactivation
and recurrent disease. Semin Ophthalmol 2008;23:249e73.
20. Harris SA, Harris EA. Herpes simplex virus type 1 and other path-
ogens are key causative factors in sporadic Alzheimer’s disease. J
Alzheimer’s Dis 2015;48:319e53.
21. Lo¨vheim H, Gilthorpe J, Johansson A, Eriksson S, Hallmans G,
Elgh F. Herpes simplex infection and the risk of Alzheimer’s disease:
a nested case-control study. Alzheimers Dement 2015;11:587e92.
22. Lo¨vheim H, Gilthorpe J, Adolfsson R, Nilsson L-G, Elgh F. Reac-
tivated herpes simplex infection increases the risk of Alzheimer’s
disease. Alzheimers Dement 2015;11:593e9.
23. Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Costa AS,
et al. High avidity HSV-1 antibodies correlate with absence of
amnestic mild cognitive impairment conversion to Alzheimer’s dis-
ease. Brain Behav Immun 2016;58:254e60.
24. Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce
the formation of key Alzheimer’s disease molecules in cell cultures
acutely infected with herpes simplex virus type 1. PLoS One 2011;6.
e25152.
25. Bartels LJ, Danner CJ, Allen KP. Office-based Meniere’s disease
management. Oper Tech Otolayngol Head Neck Surg 2016;27:
225e34.
26. Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a
treasured natural resource of anticancer drug research and develop-
ment. Am J Chin Med 2014;42:543e59.
27. Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z. Potential role of
metabolomics apporoaches in the area of traditional Chinese medi-
cine: as pillars of the bridge between Chinese and Western medicine.
J Pharm Biomed Anal 2011;55:859e68.
28. Li S, Zhang B. Traditional Chinese medicine network pharmacology:
theory, methodology and application. Chin J Nat Med 2013;11:
110e20.
29. Shen CY, Jiang JG, Yang L, Wang DW, Zhu W. Anti-ageing active
ingredients from herbs and nutraceuticals used in traditional Chinese
medicine: pharmacological mechanisms and implications for drug
discovery. Br J Pharmacol 2017;174:1395e425.
30. Zhu SR, Luo X, Li YF, Hiroshi K, He RR. Emotional stress-induced
Shanghuo syndrome increases disease susceptibility. China J Chin
Mater Med 2018;43:1529e35.
31. He RR, Kurihara H. Shanghuo syndrome in traditional Chinese
medicine. World Sci Technol 2008;10:37e41.
32. Li Y, Qin L, Jiao Y, Zhou Y, Xu L. Relationship of seven emotions
and excessive internal heat. J Tradit Complement Med 2017;32:
443e5.
33. Ives AM, Bertke AS. Stress hormones epinephrine and corticosterone
selectively modulate herpes simplex virus 1 (HSV-1) and HSV-2
productive infections in adult sympathetic, but not sensory, neu-
rons. J Virol 2017;91. e00582-17.
34. Perng GC, Osorio N, Jiang X, Geertsema R, Hsiang C, Brown D,
et al. Large amounts of reactivated virus in tears precedes recurrent
herpes stromal keratitis in stressed rabbits latently infected with
herpes simplex virus. Curr Eye Res 2016;41:284e91.
35. Ashcraft KA, Bonneau RH. Psychological stress exacerbates primary
vaginal herpes simplex virus type 1 (HSV-1) infection by impairing
both innate and adaptive immune responses. Brain Behav Immun
2008;22:1231e40.
36. Ashcraft KA, Hunzeker J, Bonneau RH. Psychological stress impairs
the local CD8þ T cell response to mucosal HSV-1 infection and
allows for increased pathogenicity via a glucocorticoid receptor-
mediated mechanism. Psychoneuroendocrinology 2008;33:951e63.
37. Bieniasz PD. Intrinsic immunity: a front-line defense against viral
attack. Nat Immunol 2004;5:1109e15.
38. Yordy B, Iwasaki A. Cell type-dependent requirement of autophagy
in HSV-1 antiviral defense. Autophagy 2013;9:236e8.
39. He RR, Yao XS, Li HY, Dai Y, Duan YH, Li YF, et al. The anti-stress
effects of Sarcandra glabra extract on restraint-evoked immuno-
compromise. Biol Pharm Bull 2009;32:247e52.Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.40. He RR, Tsoi B, Li YF, Yao XS, Kurihara H. The anti-stress effects of
Guangdong herbal tea on immunocompromise in mice loaded with
restraint stress. J Health Sci 2011;57:255e63.
41. He RR, Wang M, Wang CZ, Chen BT, Lu CN, Yao XS, et al. Pro-
tective effect of apple polyphenols against stress-provoked influenza
viral infection in restraint mice. J Agric Food Chem 2011;59:
3730e7.
42. Chen H, Jie C, Tang LP, Meng H, Li XB, Li YB, et al. New insights
into the effects and mechanism of a classic traditional Chinese me-
dicinal formula on influenza prevention. Phytomedicine 2017;27:
52e62.
43. Cao HJ, Tan RR, He RR, Tang LP, Wang XL, Yao N, et al. Sarcandra
glabra extract reduces the susceptibility and severity of influenza in
restraint-stressed mice. Evid Based Complement Alternat Med 2012;
2012:236539.
44. Tang LP, Mao ZF, Li XX, Chen M, Li SB, Tsoi B, et al. ReDuNing, a
patented Chinese medicine, reduces the susceptibility to H1N1
influenza of mice loaded with restraint stress. Eur J Integr Med 2014;
6:637e45.
45. Cai Y, Li YF, Tang LP, Tsoi B, Chen M, Chen H, et al. A new
mechanism of vitamin C effects on A/FM/1/47(H1N1) virus-induced
pneumonia in restraint-stressed mice. BioMed Res Int 2015;2015:
675149.
46. Jie C, Luo Z, Chen H, Wang M, Yan C, Mao ZF, et al. Indirubin, a
bisindole alkaloid from Isatis indigotica, reduces H1N1 susceptibil-
ity in stressed mice by regulating MAVS signaling. Oncotarget 2017;
8:105615e29.
47. Ortiz GC, Sheridan JF, Marucha PT. Stress-induced changes in
pathophysiology and interferon gene expression during primary
HSV-1 infection. Brain Behav Immun 2003;17:329e38.
48. Dong-Newsom P, Powell ND, Bailey MT, Padgett DA, Sheridan JF.
Repeated social stress enhances the innate immune response to a
primary HSV-1 infection in the cornea and trigeminal ganglia of
Balb/c mice. Brain Behav Immun 2010;24:273e80.
49. Chen M, Meng Q, Qin Y, Liang P, Tan P, He L, et al. TRIM14 in-
hibits cGAS degradation mediated by selective autophagy receptor
p62 to promote innate immune responses.Mol Cell 2016;64:105e19.
50. Enquist LW, Leib DA. Intrinsic and innate defenses of neurons:
de´tente with the herpesviruses. J Virol 2017;91:e01200e16.
51. Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. A neuron-specific
role for autophagy in antiviral defense against herpes simplex virus.
Cell Host Microbe 2012;12:334e45.
52. Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular
immune responses. Immunity 2013;39:211e27.
53. Katzenell S, Leib DA. Herpes simplex virus and interferon signaling
induce novel autophagic clusters in sensory neurons. J Virol 2016;90:
4706e19.
54. Liang Q, Seo GJ, Choi YJ, Kwak MJ, Ge J, Rodgers MA, et al.
Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy
protein shapes innate antimicrobial immune responses. Cell Host
Microbe 2014;15:228e38.
55. Su C, Zhan G, Zheng C. Evasion of host antiviral innate immunity by
HSV-1, an update. Virol J 2016;13:38.
56. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. Recognition of
herpesviruses by the innate immune system. Nat Rev Immunol 2011;
11:143e54.
57. O’Connell D, Liang C. Autophagy interaction with herpes simplex
virus type-1 infection. Autophagy 2016;12:451e9.
58. Rosato PC, Leib DA. Neurons versus herpes simplex virus: the innate
immune interactions that contribute to a host-pathogen standoff.
Future Virol 2015;10:699e714.
59. Leib DA, Alexander DE, Cox D, Yin J, Ferguson TA. Interaction of
ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 path-
ogenesis through control of CD4þ T-cell responses. J Virol 2009;83:
12164e71.
60. Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, Zhang W, et al.
HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1
autophagy protein. Cell Host Microbe 2007;1:23e35.increases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
14 Chang Yan et al.
+ MODEL61. Ogata M, Hino SI, Saito A, Morikawa K, Kondo S, Kanemoto S,
et al. Autophagy is activated for cell survival after endoplasmic re-
ticulum stress. Mol Cell Biol 2006;26:9220e31.
62. Murrow L, Debnath J. Autophagy as a stress-response and quality-
control mechanism: implications for cell injury and human disease.
Annu Rev Pathol 2013;8:105e37.
63. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-
edged sword. Science 2004;306:990e5.
64. Wang S, Long J, Zheng CF. The potential link between PML NBs
and ICP0 in regulating lytic and latent infection of HSV-1. Protein
Cell 2012;3:372e82.
65. Kukhanova MK, Korovina AN, Kochetkov SN. Human herpes sim-
plex virus: life cycle and development of inhibitors. Biochemistry
(Mosc) 2014;79:1635e52.
66. Zhou G, Du T, Roizman B. The role of the CoREST/REST repressor
complex in herpes simplex virus 1 productive infection and in la-
tency. Viruses 2013;5:1208e18.
67. Roizman B. The checkpoints of viral gene expression in productive
and latent infection: the role of the HDAC/CoREST/LSD1/REST
repressor complex. J Virol 2011;85:7474e82.
68. Hafezi W, Lorentzen EU, Eing BR, Mu¨ller M, King NJ, Klupp B,
et al. Entry of herpes simplex virus type 1 (HSV-1) into the distal
axons of trigeminal neurons favors the onset of nonproductive, silent
infection. PLoS Pathog 2012;8:e1002679.
69. Xu P, Mallon S, Roizman B. PML plays both inimical and beneficial
roles in HSV-1 replication. Proc Natl Acad Sci U S A 2016;113:
E3022e8.
70. Xu P, Roizman B. The SP100 component of ND10 enhances accu-
mulation of PML and suppresses replication and the assembly of
HSV replication compartments. Proc Natl Acad Sci U S A 2017;114:
E3823e9.
71. Koyuncu OO, Song R, Greco TM, Cristea IM, Enquist LW. The
number of alphaherpesvirus particles infecting axons and the axonal
protein repertoire determines the outcome of neuronal infection.
mBio 2015;6. e00276-15.
72. Ellison AR, Yang L, Voytek C, Margolis TP. Establishment of latent
herpes simplex virus type 1 infection in resistant, sensitive, and
immunodeficient mouse strains. Virology 2000;268:17e28.
73. Rosato PC, Katzenell S, Pesola JM, North B, Coen DM, Leib DA.
Neuronal IFN signaling is dispensable for the establishment of HSV-
1 latency. Virology 2016;497:323e7.
74. Perng GC, Slanina SM, Yukht A, Ghiasi H, Nesburn AB,
Wechsler SL. The latency-associated transcript gene enhances
establishment of herpes simplex virus type 1 latency in rabbits. J
Virol 2000;74:1885e91.
75. Zheng X, Marquart ME, Loustch JM, Shah P, Sainz B, Ray A,
et al. HSV-1 migration in latently infected and naive rabbits after
penetrating keratoplasty. Investig Ophthalmol Vis Sci 1999;40:
2490e7.
76. Al-Dujaili LJ, Clerkin PP, Clement C, McFerrin HE,
Bhattacharjee PS, Varnell ED, et al. Ocular herpes simplex virus:
how are latency, reactivation, recurrent disease and therapy interre-
lated?. Future Microbiol 2011;6:877e907.
77. Shimomura Y, Mori Y, Inoue Y, Kiritooshi A, Ohashi Y, Manabe R.
Herpes simplex virus latency in human cornea. Jpn J Ophthalmol
1993;37:318e24.
78. Pavan-Langston D, Rong BL, Dunkel EC. Extraneuronal herpetic
latency: animal and human corneal studies. Acta Ophthalmol Suppl
1989;192:135e41.
79. Kaye SB, Baker K, Bonshek R, Maseruka H, Grinfeld E, Tullo A,
et al. Human herpesviruses in the cornea. Br J Ophthalmol 2000;84:
563e71.
80. Higaki S, Fukuda M, Shimomura Y. Virological and molecular bio-
logical evidence supporting herpes simplex virus type 1 corneal la-
tency. Jpn J Ophthalmol 2015;59:131e4.
81. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW,
Hill JM. HSV-1 DNA in tears and saliva of normal adults. Investig
Ophthalmol Vis Sci 2005;46:241e7.Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.82. Fukuda M, Deai T, Higaki S, Hayashi K, Shimomura Y. Presence of a
large amount of herpes simplex virus genome in tear fluid of herpetic
stromal keratitis and persistent epithelial defect patients. Semin
Ophthalmol 2008;23:217e20.
83. Kennedy DP, Clement C, Arceneaux RL, Bhattacharjee PS, Huq TS,
Hill JM. Ocular herpes simplex virus type 1: is the cornea a reservoir
for viral latency or a fast pit stop?. Cornea 2011;30:251e9.
84. Kennedy PG, Cohrs RJ. Varicella-zoster virus human ganglionic la-
tency: a current summary. J Neurovirol 2010;16:411e8.
85. Kimberlin DW, Whitley RJ. Antiviral therapy of HSV-1 and-2. In:
Arvin AC-FG, Mocarski E, et al., editors. Human herpesviruses:
biology, therapy, and immunoprophylaxis. Cambridge: Cambridge
University Press; 2007. p. 1153e74.
86. Snoeck R. Antiviral therapy of herpes simplex. Int J Antimicrob
Agents 2000;16:157e9.
87. Stow ND, Stow EC. Isolation and characterization of a herpes sim-
plex virus type 1 mutant containing a deletion within the gene
encoding the immediate early polypeptide Vmw110. J Gen Virol
1986;67:2571e85.
88. Valyi-Nagy T, Fareed MU, O’Keefe JS, Gesser RM, MacLean AR,
Brown SM, et al. The herpes simplex virus type 1 strain 17þ gamma
34.5 deletion mutant 1716 is avirulent in SCID mice. J Gen Virol
1994;75:2059e63.
89. Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR,
Bloom DC. Mutational inactivation of herpes simplex virus 1
microRNAs identifies viral mRNA targets and reveals phenotypic
effects in culture. J Virol 2013;87:6589e603.
90. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM,
Cullen BR. MicroRNAs expressed by herpes simplex virus 1 during
latent infection regulate viral mRNAs. Nature 2008;454:780e3.
91. Shen W, Sa e Silva M, Jaber T, Vitvitskaia O, Li S, Henderson G,
et al. Two small RNAs encoded within the first 1.5 kilobases of the
herpes simplex virus type 1 latency-associated transcript can inhibit
productive infection and cooperate to inhibit apoptosis. J Virol 2009;
83:9131e9.
92. Nicoll MP, Hann W, Shivkumar M, Harman LE, Connor V,
Coleman HM, et al. The HSV-1 latency-associated transcript func-
tions to repress latent phase lytic gene expression and suppress virus
reactivation from latently infected neurons. PLoS Pathog 2016;12.
e1005539.
93. Jiang X, Brown D, Osorio N, Hsiang C, BenMohamed L,
Wechsler SL. Increased neurovirulence and reactivation of the herpes
simplex virus type 1 latency-associated transcript (LAT)-negative
mutant dLAT2903 with a disrupted LAT miR-H2. J Neurovirol 2016;
22:38e49.
94. Nicoll MP, Proenca JT, Connor V, Efstathiou S. Influence of herpes
simplex virus 1 latency-associated transcripts on the establishment
and maintenance of latency in the ROSA26R reporter mouse model.
J Virol 2012;86:8848e58.
95. You Y, Cheng AC, Wang MS, Jia RY, Sun KF, Yang Q, et al. The
suppression of apoptosis by alpha-herpesvirus. Cell Death Dis 2017;
8:e2749.
96. Carpenter D, Hsiang C, Jiang X, Osorio N, BenMohamed L, Jones C,
et al. The herpes simplex virus type 1 (HSV-1) latency-associated
transcript (LAT) protects cells against cold-shock-induced
apoptosis by maintaining phosphorylation of protein kinase B
(AKT). J Neurovirol 2015;21:568e75.
97. Jones C. Bovine herpes virus 1 (BHV-1) and herpes simplex virus
type 1 (HSV-1) promote survival of latently infected sensory neurons,
in part by inhibiting apoptosis. J Cell Death 2013;6:1e16.
98. Jiang XZ, Chentoufi AA, Hsiang CH, Carpenter D, Osorio N,
BenMohamed L, et al. The herpes simplex virus type 1 latency-
associated transcript can protect neuron-derived C1300 and Neu-
ro2A cells from granzyme B-induced apoptosis and CD8 T-cell
killing. J Virol 2011;85:2325e32.
99. Carpenter D, Hsiang C, Brown DJ, Jin L, Osorio N, BenMohamed L,
et al. Stable cell lines expressing high levels of the herpes simplex
virus type 1 LAT are refractory to caspase 3 activation and DNAincreases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
Stress increases the susceptibility to HSV-1 primary and recurrent infections 15
+ MODELladdering following cold shock induced apoptosis. Virology 2007;
369:12e8.
100. Piedade D, Azevedo-Pereira JM. The role of microRNAs in the
pathogenesis of herpesvirus infection. Viruses 2016;8:156.
101. Duan F, Ni S, Nie Y, Huang Q, Wu K. Small interfering RNA tar-
geting for infected-cell polypeptide 4 inhibits herpes simplex virus
type 1 replication in retinal pigment epithelial cells. Clin Exp Oph-
thalmol 2012;40:195e204.
102. Duan F, Liao J, Huang Q, Nie Y, Wu K. HSV-1 miR-H6 inhibits
HSV-1 replication and IL-6 expression in human corneal epithelial
cells in vitro. Clin Dev Immunol 2012;2012:192791.
103. Jiang X, Brown D, Osorio N, Hsiang C, Li L, Chan L, et al. A herpes
simplex virus type 1 mutant disrupted for microRNA H2 with
increased neurovirulence and rate of reactivation. J Neurovirol 2015;
21:199e209.
104. Rosato PC, Leib DA. Neuronal interferon signaling is required for
protection against herpes simplex virus replication and pathogenesis.
PLoS Pathog 2015;11. e1005028.
105. Mattila RK, Harila K, Kangas SM, Paavilainen H, Heape AM,
Mohr IJ, et al. An investigation of herpes simplex virus type 1 latency
in a novel mouse dorsal root ganglion model suggests a role for
ICP34.5 in reactivation. J Gen Virol 2015;96:2304e13.
106. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW.
Anti-apoptotic function of a microRNA encoded by the HSV-1 la-
tency-associated transcript. Nature 2006;442:82e5.
107. Sanchez EL, Lagunoff M. Viral activation of cellular metabolism.
Virology 2015;479e480:609e18.
108. Leyton L, Hott M, Acun˜a F, Caroca J, Nun˜ez M, Martin C, et al.
Nutraceutical activators of AMPK/Sirt1 axis inhibit viral production
and protect neurons from neurodegenerative events triggered during
HSV-1 infection. Virus Res 2015;205:63e72.
109. Martin C, Leyton L, Arancibia Y, Cuevas A, Zambrano A,
Concha MI, et al. Modulation of the AMPK/Sirt1 axis during
neuronal infection by herpes simplex virus type 1. J Alzheimer’s Dis
2014;42:301e12.
110. Audas TE, Hardy-Smith PW, Penney J, Taylor T, Lu R. Character-
ization of nuclear foci-targeting of Luman/CREB3 recruitment factor
(LRF/CREBRF) and its potential role in inhibition of herpes simplex
virus-1 replication. Eur J Cell Biol 2016;95:611e22.
111. Camarena V, Kobayashi M, Kim JY, Roehm P, Perez R, Gardner J,
et al. Nature and duration of growth factor signaling through receptor
tyrosine kinases regulates HSV-1 latency in neurons. Cell Host
Microbe 2010;8:320e30.
112. Wilcox CL, Smith RL, Freed CR, Johnson Jr EM. Nerve growth
factor-dependence of herpes simplex virus latency in peripheral
sympathetic and sensory neurons in vitro. J Neurosci 1990;10:
1268e75.
113. Danaher RJ, Jacob RJ, Miller CS. Establishment of a quiescent
herpes simplex virus type 1 infection in neurally-differentiated PC12
cells. J Neurovirol 1999;5:258e67.
114. Hill JM, Garza Jr HH, Helmy MF, Cook SD, Osborne PA,
Johnson Jr EM, et al. Nerve growth factor antibody stimulates
reactivation of ocular herpes simplex virus type 1 in latently infected
rabbits. J Neurovirol 1997;3:206e11.
115. Zhou G, Du T, Roizman B. HSV carrying WT REST establishes
latency but reactivates only if the synthesis of REST is suppressed.
Proc Natl Acad Sci U S A 2013;110:E498e506.
116. Lambiase A, Coassin M, Costa N, Lauretti P, Micera A, Ghinelli E,
et al. Topical treatment with nerve growth factor in an animal model
of herpetic keratitis. Graefes Arch Clin Exp Ophthalmol 2008;246:
121e7.
117. Liu X, Cohen JI. The role of PI3K/Akt in human herpesvirus
infection: from the bench to the bedside. Virology 2015;479e480:
568e77.
118. Kobayashi M, Wilson AC, Chao MV, Mohr I. Control of viral latency
in neurons by axonal mTOR signaling and the 4E-BP translation
repressor. Genes Dev 2012;26:1527e32.Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.119. Huang J, Kent JR, Placek B, Whelan KA, Hollow CM, Zeng PY,
et al. Trimethylation of histone H3 lysine 4 by Set1 in the lytic
infection of human herpes simplex virus 1. J Virol 2006;80:
5740e6.
120. Kubat NJ, Amelio AL, Giordani NV, Bloom DC. The herpes simplex
virus type 1 latency-associated transcript (LAT) enhancer/rcr is
hyperacetylated during latency independently of LAT transcription. J
Virol 2004;78:12508e18.
121. Clement C, Bhattacharjee PS, Kumar M, Foster TP, Thompson HW,
Hill JM. Upregulation of mouse genes in HSV-1 latent TG after
butyrate treatment implicates the multiple roles of the LAT-ICP0
locus. Investig Ophthalmol Vis Sci 2011;52:1770e9.
122. Hill JM, Quenelle DC, Cardin RD, Vogel JL, Clement C, Bravo FJ,
et al. Inhibition of LSD1 reduces herpesvirus infection, shedding, and
recurrence by promoting epigenetic suppression of viral genomes.
Sci Transl Med 2014;6:265ra169.
123. Guo J, Li N, Han J, Pei F, Wang T, Lu D, et al. DNA recognition
patterns of the multi-zinc-finger protein CTCF: a mutagenesis study.
Acta Pharm Sin B 2018;8:900e8.
124. Bloom DC, Giordani NV, Kwiatkowski DL. Epigenetic regulation of
latent HSV-1 gene expression. Biochim Biophys Acta 2010;1799:
246e56.
125. Egan KP, Wu S, Wigdahl B, Jennings SR. Immunological control of
herpes simplex virus infections. J Neurovirol 2013;19:328e45.
126. Ma JZ, Russell TA, Spelman T, Carbone FR, Tscharke DC. Lytic
gene expression is frequent in HSV-1 latent infection and correlates
with the engagement of a cell-intrinsic transcriptional response. PLoS
Pathog 2014;10. e1004237.
127. van Velzen M, Jing L, Osterhaus AD, Sette A, Koelle DM,
Verjans GM. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens
documents broad viral protein expression and immune competence in
latently infected human trigeminal ganglia. PLoS Pathog 2013;9.
e1003547.
128. Sheridan BS, Cherpes TL, Urban J, Kalinski P, Hendricks RL.
Reevaluating the CD8 T-cell response to herpes simplex virus type 1:
involvement of CD8 T cells reactive to subdominant epitopes. J Virol
2009;83:2237e45.
129. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR,
Hendricks RL. Noncytotoxic lytic granule-mediated CD8þ T cell
inhibition of HSV-1 reactivation from neuronal latency. Science
2008;322:268e71.
130. Held K, Derfuss T. Control of HSV-1 latency in human trigeminal
ganglia-current overview. J Neurovirol 2011;17:518e27.
131. Ghiasi H, St Leger AJ, Jeon S, Hendricks RL. Broadening the
repertoire of functional herpes simplex virus type 1-specific CD8þ T
cells reduces viral reactivation from latency in sensory ganglia. J
Virol 2013;191:2258e65.
132. Finsterbusch K, Piguet V. Down-RANKing the threat of HSV-1:
RANKL upregulates MHC-Class-I-restricted anti-viral immunity in
herpes simplex virus infection. J Investig Dermatol 2015;135:
2565e7.
133. Srivastava R, Dervillez X, Khan AA, Chentoufi AA, Chilukuri S,
Shukr N, et al. The herpes simplex virus latency-associated transcript
gene is associated with a broader repertoire of virus-specific
exhausted CD8þ T cells retained within the trigeminal ganglia of
latently infected HLA transgenic rabbits. J Virol 2016;90:3913e28.
134. Frank GM, Lepisto AJ, Freeman ML, Sheridan BS, Cherpes TL,
Hendricks RL. Early CD4þ T cell help prevents partial CD8þ T cell
exhaustion and promotes maintenance of herpes simplex virus 1 la-
tency. J Immunol 2010;184:277e86.
135. Mott KR, Gate D, Matundan HH, Ghiasi YN, Town T, Ghiasi H.
CD8þ T cells play a bystander role in mice latently infected with
herpes simplex virus 1. J Virol 2016;90:5059e67.
136. Mott KR, Allen SJ, Zandian M, Ghiasi H. Coregulatory interactions
among CD8alpha dendritic cells, the latency-associated transcript,
and programmed death 1 contribute to higher levels of herpes sim-
plex virus 1 latency. J Virol 2014;88:6599e610.increases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
16 Chang Yan et al.
+ MODEL137. Kennedy PG, Rovnak J, Badani H, Cohrs RJ. A comparison of herpes
simplex virus type 1 and varicella-zoster virus latency and reac-
tivation. J Gen Virol 2015;96:1581e602.
138. Jiang CY, Huang JW, Jie C, Yan C, Li YT, Kurihara H, et al. Wan-
glaoji herbal tea protects against influenza-induced pneumonia in
restraint-stressed mice via its anti-inflammatory effects. Int J Phar-
macol 2018;14:342e51.
139. Li YF, He RR, Tsoi B, Li XD, Li WX, Abe K, et al. Anti-stress
effects of carnosine on restraint-evoked immunocompromise in mice
through spleen lymphocyte number maintenance. PLoS One 2012;7.
e33190.
140. Sinani D, Cordes E, Workman A, Thunuguntia P, Jones C. Stress-
induced cellular transcription factors expressed in trigeminal
ganglionic neurons stimulate the herpes simplex virus 1 ICP0 pro-
moter. J Virol 2013;87:13042e7.
141. Kushnir AS, Davido DJ, Schaffer PA. Role of nuclear factor Y in
stress-induced activation of the herpes simplex virus type 1 ICP0
promoter. J Virol 2010;84:188e200.
142. Curtin NM, Boyle NT, Mills KH, Connor TJ. Psychological stress
suppresses innate IFN-gamma production via glucocorticoid receptor
activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav
Immun 2009;23:535e47.
143. Noisakran S, Halford WP, Veress L, Carr DJ. Role of the hypotha-
lamic pituitary adrenal axis and IL-6 in stress-induced reactivation of
latent herpes simplex virus type 1. J Immunol 1998;160:5441e7.
144. Ostler JB, Harrison KS, Schroeder K, Thunuguntla P, Jones C. The
glucocorticoid receptor (GR) stimulates herpes simplex virus 1
productive infection, in part because the infected cell protein
0 (ICP0) promoter is cooperatively transactivated by the GR and
Kru¨ppel-like transcription factor 15. J Virol 2019;93. e02063-18.
145. Kook I, Jones C. The serum and glucocorticoid-regulated protein
kinases (SGK) stimulate bovine herpesvirus 1 and herpes simplex
virus 1 productive infection. Virus Res 2016;222:106e12.
146. Elftman MD, Hunzeker JT, Mellinger JC, Bonneau RH, Norbury CC,
Truckenmiller ME. Stress-induced glucocorticoids at the earliest
stages of herpes simplex virus-1 infection suppress subsequent
antiviral immunity, implicating impaired dendritic cell function. J
Immunol 2010;184:1867e75.
147. Sommershof A, Basler M, Riether C, Engler H, Groettrup M.
Attenuation of the cytotoxic T lymphocyte response to lymphocytic
choriomeningitis virus in mice subjected to chronic social stress.
Brain Behav Immun 2011;25:340e8.
148. Marketon JIW, Glaser R. Stress hormones and immune function. Cell
Immunol 2008;252:16e26.
149. Figliozzi RW, Chen F, Balish M, Ajavon A, Hsia SV. Thyroid
hormone-dependent epigenetic suppression of herpes simplex virus-1
gene expression and viral replication in differentiated neuroendocrine
cells. J Neurol Sci 2014;346:164e73.
150. Bedadala GR, Pinnoji RC, Palem JR, Hsia SC. Thyroid hormone
controls the gene expression of HSV-1 LAT and ICP0 in neuronal
cells. Cell Res 2010;20:587e98.
151. Chen F, Figliozzi RW, Bedadala G, Palem J, Hsia SV. Overexpression
of thyroid hormone receptor beta1 altered thyroid hormone-mediated
regulation of herpes simplex virus-1 replication in differentiated
cells. J Neurovirol 2016;22:555e63.
152. Chen F, Palem J, Balish M, Figliozzi R, Ajavon A, Hsia SV. A novel
thyroid hormone mediated regulation of HSV-1 gene expression and
replication is specific to neuronal cells and associated with disruption
of chromatin condensation. SOJ Pharm Pharm Sci 2014;1:7.Please cite this article as: Yan C et al., Disturbed YineYang balance: stress
simplex virus type 1, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.153. Hsia SC, Bedadala GR, Balish MD. Effects of thyroid hormone on
HSV-1 gene regulation: implications in the control of viral latency
and reactivation. Cell Biosci 2011;1:24.
154. Neumann DM, Bhattacharjee PS, Giordani NV, Bloom DC, Hill JM.
In vivo changes in the patterns of chromatin structure associated with
the latent herpes simplex virus type 1 genome in mouse trigeminal
ganglia can be detected at early times after butyrate treatment. J Virol
2007;81:13248e53.
155. Wang QY, Zhou C, Johnson KE, Colgrove RC, Coen DM,
Knipe DM. Herpesviral latency-associated transcript gene promotes
assembly of heterochromatin on viral lytic-gene promoters in latent
infection. Proc Natl Acad Sci U S A 2005;102:16055e9.
156. Avgousti DC, Weitzman MD. Stress flips a chromatin switch to wake
up latent virus. Cell Host Microbe 2015;18:639e41.
157. Kim JY, Mandarino A, Chao MV, Mohr I, Wilson AC. Transient
reversal of episome silencing precedes VP16-dependent transcription
during reactivation of latent HSV-1 in neurons. PLoS Pathog 2012;8:
e1002540.
158. Thompson RL, Preston CM, Sawtell NM. De novo synthesis of VP16
coordinates the exit from HSV latency in vivo. PLoS Pathog 2009;5.
e1000352.
159. Danaher RJ, Cook RK, Wang C, Triezenberg SJ, Jacob RJ, Miller CS.
C-terminal trans-activation sub-region of VP16 is uniquely required
for forskolin-induced herpes simplex virus type 1 reactivation from
quiescently infected-PC12 cells but not for replication in neuronally
differentiated-PC12 cells. J Neurovirol 2013;19:32e41.
160. Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Atwal E,
Rubsamen-Waigmann H, et al. Efficacy of a helicase-primase in-
hibitor in animal models of ocular herpes simplex virus type 1
infection. J Ocul Pharmacol Ther 2008;24:34e42.
161. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, et al.
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in
response to ROS. Proc Natl Acad Sci U S A 2010;107:4153e8.
162. Du T, Zhou G, Roizman B. Induction of apoptosis accelerates reac-
tivation of latent HSV-1 in ganglionic organ cultures and replication in
cell cultures. Proc Natl Acad Sci U S A 2012;109:14616e21.
163. Kim JC, Choi SH, Kim JK, Kim Y, Kim HJ, Im JS, et al. Herpes
simplex virus type 1 ICP27 induces apoptotic cell death by
increasing intracellular reactive oxygen species. Mol Biol (Mosk)
2008;42:470e7.
164. Aravantinou M, Frank I, Arrode-Bruses G, Szpara M, Grasperge B,
Blanchard J, et al. A model of genital herpes simplex virus type 1
infection in rhesus macaques. J Med Primatol 2017;46:121e8.
165. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction:
implications for health. Nat Rev Immunol 2005;5:243e51.
166. Edgar RS, Stangherlin A, Nagy AD, Nicoll MP, Efstathiou S,
O’Neill JS, et al. Cell autonomous regulation of herpes and influenza
virus infection by the circadian clock. Proc Natl Acad Sci U S A
2016;113:10085e90.
167. Li W, Wang X-H, Luo Z, Liu L-F, Yan C, Yan C-Y, et al. Traditional
Chinese medicine as a potential source for HSV-1 therapy by acting
on virus or the susceptibility of host. Int J Mol Sci 2018;19:3266.
168. Gu P, Chen H. Modern bioinformatics meets traditional Chinese
medicine. Briefings Bioinf 2014;15:984e1003.
169. Zhao J, Jiang P, Zhang W. Molecular networks for the study of TCM
pharmacology. Briefings Bioinf 2010;11:417e30.
170. Li P, Yang LP, Gong YW. Application of systems biology technology
in research of traditional Chinese medicine. J Tradit Chin Med 2009;
29:153e7.increases the susceptibility to primary and recurrent infections of herpes
apsb.2019.06.005
